F. Breillout

540 citations
22 papers · 460 · h-index 12

Impact in

Papers in

    • Cancer Treatment and Pharmacology 11
    • Colorectal Cancer Treatments and Studies 2
    • Cancer Cells and Metastasis 2
    • Cancer therapeutics and mechanisms 2

F. Breillout

21 papers receiving 442 citations

Peers

F. Breillout
Comparison fields: 5 of 68
  • Biotechnology 108
  • Biochemistry 64
  • Oncology 236
  • Pharmacology 45
  • Cancer Research 61
Replace David A. Litvak with:
David A. Litvak United States
Yunpeng Sun China
Laura González-Santiago Spain
Yi-Chieh Yang Taiwan
Yuichi Koga Japan
Hirokazu Sugimoto Japan
Toran Sanli Canada
Wenjie Zhang China
Yoav Shetzer Israel
E Chinje United Kingdom
F. Breillout relative to David A. Litvak United States David A. Litvak's profile →
Citations per field
00.5×4.3×
David A. Litvak · 1×
Citations per year

Countries citing papers authored by F. Breillout

Since Specialization
Citations

This map shows the geographic impact of F. Breillout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Breillout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Breillout more than expected).

Fields of papers citing papers by F. Breillout

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Breillout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Breillout. The network helps show where F. Breillout may publish in the future.

Co-authors

The 25 scholars most cited alongside F. Breillout, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F. Breillout Line = papers co-authored together F. Breillout links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1 199096
2
Pharmacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography.
199168
3
Decreased rat rhabdomyosarcoma pulmonary metastases in response to a low methionine diet.
198750
4 199340
5 199928
6 199125
7 199224
8 200521
9 200821
10 198818
11 198715
12 199412
13 198911
14 200810
15
5'-Nor-anhydrovinblastine (Navelbine) has an anti-invasive effect on MO4 mouse fibrosarcoma cells in vitro and in vivo.
19935
16
Concomitant decrease of resistance and modifications of the cytoskeleton after all-trans retinoic acid and phorbol ester treatments in a navelbine-resistant bladder carcinoma cell line.
19975
17 20073
18 19933
19 20112
20 20092

About F. Breillout

F. Breillout is a scholar working on Oncology, Molecular Biology, Cell Biology, Biotechnology and Biochemistry, having authored 22 papers that have together received 460 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Microtubule and mitosis dynamics (6 papers), Cancer Research and Treatments (4 papers), Amino Acid Enzymes and Metabolism (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer therapeutics and mechanisms (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Biotechnology (108 citations), Biochemistry (64 citations), Oncology (236 citations), Pharmacology (45 citations) and Cancer Research (61 citations). F. Breillout has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include M.F. Poupon, A Krikorian, F. Jehl, Dominique Levêque, Élisabeth Quoix, H. Monteil, Guido F. Pauli, Saı̈k Urien, G. Bastian and J.P. Tillement. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Cancer Chemotherapy and Pharmacology, Anti-Cancer Drugs, British Journal of Cancer and Seminars in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact